<DOC>
	<DOCNO>NCT00351871</DOCNO>
	<brief_summary>The objective study well understand influence insulin resistance upon treatment response hepatitis C virus treat PEG Intron Rebetol .</brief_summary>
	<brief_title>Influence Marker Insulin Resistance Upon Hepatitis C Virus ( HCV ) Treatment Responses PEG Intron Rebetol Therapy</brief_title>
	<detailed_description>The relationship HCV IR evolve one . This study allow formal evaluation relationship . Four hundred patient treat use weight base Peg Intron Rebetol . Clinical biochemical data relate IR collect determine factor predict sustain virological response . To evaluate patient insulin resistance , HOMA score ( product fast insulin level blood glucose level ) , waist circumference , body mass index measure .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Evidence chronic hepatitis C infection ( viremia ) RTPCR superquantitative HCV Genotype 1 Liver biopsy within 36 month enrollment consistent chronic hepatitis Compensated liver disease laboratory parameter entry visit follow : Hemoglobin value &gt; 12 gm/dL WBC &gt; 2,500/mm3 Neutrophil count &gt; 1,000/mm3 Platelets &gt; 100,000/mm3 Prothrombin time &lt; 2 second prolonged compare control , equivalent INR ratio Bilirubin within 20 % upper limit normal unless nonhepatitis related factor exist Gilbert 's syndrome . Albumin &gt; 3.0 g/dL Serum creatinine &lt; 1.4 mg/dL Normal thyroid stimulate hormone ( TSH ) thyroid disease clinically control Antinuclear antibody ( ANA ) &lt; 1:160 FBS &lt; 126 mg/dl No significant coexist psychiatric disease Free substance abuse past 2 year Previous treatment HCV . Evidence HIV positive . Hypersensitivity alpha interferon , Peg Intron Rebetol . Any cause chronic liver disease chronic hepatitis C besides obesity . Hemoglobinopathies ( e.g. , Thalassemia ) cause hemolytic anemia . Evidence advance liver disease history presence ascites , bleed varix , hepatic encephalopathy . Preexisting medical condition could interfere patient 's participation protocol include : CNS trauma active seizure disorder require medication ; diabetes mellitus ; serious pulmonary disease ; immunologically mediate disease ; gout attack within 12 month ; medical condition requiring , likely require course study , chronic systemic administration steroid . Patients evidence ischemia stress testing , arrhythmia , cardiac failure , coronary surgery , uncontrolled hypertension , angina myocardial infarction within 12 month . Patients history organ transplantation exclude . Patients take insulin sensitize drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>HCV</keyword>
</DOC>